Abdul-Aziz, M., Cheng, V., Burrows, F., Buscher, H., Cho, Y., Corley, A., Diehl, A., Gilder, E., Kim, H., Levkovich, B., Lim, S., Liu, X., McGuinness, S., Ordonez, J., Parke, R., Pellegrino, V., Reynolds, C., Rudham, S., Wallis, S., Welch, S., Fraser, J., Shekar, K., Roberts, J. Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkag090
Abstract: To describe meropenem population pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation (ECMO) with or without renal replacement therapy (RRT), and to identify dosing regimens likely to achieve safe and effective exposures.